Business Description
OraSure Technologies Inc
NAICS : 339112
SIC : 3841
ISIN : US68554V1089
Share Class Description:
FRA:EP3: Ordinary SharesTotal Employee Number:
500Description
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.98 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.2 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.39 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.6 | |||||
3-Year FCF Growth Rate | 22.1 | |||||
3-Year Book Growth Rate | -1.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 26.19 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.31 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.49 | |||||
9-Day RSI | 65.14 | |||||
14-Day RSI | 65.49 | |||||
3-1 Month Momentum % | 41.09 | |||||
6-1 Month Momentum % | 76.7 | |||||
12-1 Month Momentum % | 42.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.46 | |||||
Quick Ratio | 4.77 | |||||
Cash Ratio | 4.01 | |||||
Days Inventory | 183.1 | |||||
Days Sales Outstanding | 76.69 | |||||
Days Payable | 42.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 7.16 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.21 | |||||
Operating Margin % | -64.62 | |||||
Net Margin % | -66.42 | |||||
EBITDA Margin % | -56.26 | |||||
FCF Margin % | -42.38 | |||||
OCF Margin % | -38.23 | |||||
ROE % | -20.93 | |||||
ROA % | -17.8 | |||||
ROIC % | -38.61 | |||||
3-Year ROIIC % | 73.13 | |||||
ROC (Joel Greenblatt) % | -89.32 | |||||
ROCE % | -19.06 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 29.75 | |||||
Shiller PE Ratio | 297.72 | |||||
PS Ratio | 2.85 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 1.23 | |||||
EV-to-EBIT | -1.95 | |||||
EV-to-EBITDA | -2.25 | |||||
EV-to-Revenue | 1.26 | |||||
EV-to-Forward-Revenue | 1.96 | |||||
EV-to-FCF | -2.98 | |||||
Price-to-GF-Value | 2.26 | |||||
Price-to-Projected-FCF | 6 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
| Price-to-Net-Current-Asset-Value | 1.77 | |||||
| Price-to-Net-Cash | 2.78 | |||||
Earnings Yield (Greenblatt) % | -51.28 | |||||
FCF Yield % | -15.59 | |||||
Forward Rate of Return (Yacktman) % | 26.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OraSure Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 97.174 | ||
| EPS (TTM) (€) | -0.895 | ||
| Beta | 0.6801 | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.12 | ||
| Volatility % | 51.2 | ||
| 14-Day RSI | 65.49 | ||
| 14-Day ATR (€) | 0.125466 | ||
| 20-Day SMA (€) | 3.632 | ||
| 12-1 Month Momentum % | 42.19 | ||
| 52-Week Range (€) | 1.8 - 3.92 | ||
| Shares Outstanding (Mil) | 68.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OraSure Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OraSure Technologies Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 17:00 | In 128 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 127 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 17:00 | In 36 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 35 days | ||
| General meeting for 2026 | 2026-06-03 09:00 | 3.42 (-1.72%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 17:00 | 2.54 (+0.79%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 2.54 (+0.79%) | ||
| Annual report for 2025 | 2026-03-09 | 2.72 (+6.25%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 17:00 | 2.38 (+2.59%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-25 | 2.38 (+2.59%) |
Show
Entries
OraSure Technologies Inc Frequently Asked Questions
What is OraSure Technologies Inc(FRA:EP3)'s stock price today?
The current price of FRA:EP3 is €3.84. The 52 week high of FRA:EP3 is €3.92 and 52 week low is €1.80.
When is next earnings date of OraSure Technologies Inc(FRA:EP3)?
The next earnings date of OraSure Technologies Inc(FRA:EP3) is 2026-08-05 Est..
Does OraSure Technologies Inc(FRA:EP3) pay dividends? If so, how much?
OraSure Technologies Inc(FRA:EP3) does not pay dividend.
Press Release
Articles on OraSure Technologies Inc
No articles.